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The innate immune sensing of pathogens is important for host to mount defensive responses. STING has 
emerged in recent year as a critical signaling adaptor in the immune response to cytosolic DNA and RNA 
derived from pathogens. Liu et al. (2016) demonstrate that the RIG-I-dependent RNA sensing signaling induces 
STING expression via a TNF-α and IFN-α synergy. The up-regulation of STING is vital for 5’pppRNA 
restriction of HSV, a DNA virus that infects humans and causes herpes, in vitro and in vivo. This study provides 
new insights into the cross talk between DNA and RNA pathogen-sensing systems via the control of STING. 
Keywords: RIG-I; MAVS; cGAS; STING; antiviral response; innate immunity; type I IFN; HSV; 5’pppRNA; RIG-I 
agonist 
To cite this article: Yiliu Liu, et al. RIGulation of STING expression: at the crossroads of viral RNA and DNA sensing 
pathways. Inflamm Cell Signal 2018; 5: e1491. doi: 10.14800/ics.1491. 
Copyright: © 2018 The Authors. Licensed under a Creative Commons Attribution 4.0 International License which 
allows users including authors of articles to copy and redistribute the material in any medium or format, in addition 
to remix, transform, and build upon the material for any purpose, even commercially, as long as the author and 
original source are p operly cited or credited. 
The innate immune system utilizes germ line-encoded 
pattern recognition receptors (PRRs) to detect pathogen 
associated molecular patterns (PAMPs) and initiate immune 
defense responses that counteract viral infection [1]. The 
discovery of the multiplicity of both cytosolic RNA and 
DNA sensing pathways has revealed an unexpected 
complexity of the host response to viral nucleic acids. 
Detection of viral nucleic acids within the cytoplasm via 
either the RIG-I-MAVS signaling axis or the cGAS-STING 
DNA sensing pathway leads to the production of antiviral 
interferons (IFNs) and pro-inflammatory cytokines [2]. While 
functioning distinctively, the DNA and RNA sensing 
mechanisms overlap at multiple levels. For instance, 
cytosolic sensing of DNA has been shown to mediate the 
activation and expression level of RIG-I [3, 4]. Recently, new 
roles of the cytosolic DNA sensor cGAS in the innate control 
of RNA viruses has been revealed [5]. In turn, there are 
indications that RNA sensing pathways may modulate host 
responses against DNA infections [6]. Recently, Liu et al. 
reported that stimulation of RIG-I using a specific 
5’pppRNA agonist induces STING expression at both the 
mRNA and protein levels. Physiologically, activation of the 
RIG-I-MAVS pathway efficiently suppresses infection by the 
DNA virus herpes simplex virus 1 (HSV-1), both in vitro and 
in vivo in a STING-dependent fashion [7]. This study provides 
new insights into the cross talk between DNA and RNA 
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pathogen-sensing systems via the control of STING. 
The signaling mechanism of the cytosolic innate immunity 
has been extensively studied and tremendous advances have 
been made recently [2]. STING is an important regulator in 
many aspects of cytosolic DNA-triggered innate immune 
responses. cGAS has been established as the universal sensor 
for cytosolic DNA from DNA viruses, bacteria, and 
retroviruses [8-11]. Once activated by direct DNA binding, it 
catalyzes the production of the second messenger, cGAMP, 
which binds and activates STING [12]. Aside from 
functioning as an adaptor downstream of cGAS and many 
other putative DNA sensors [13-16], STING also independently 
senses bacterial cyclic dinucleotides (CDNs) [17]. The RNA 
cytosolic surveillance pathways involve the family of RIG-I 
like receptors (RLR). Among which, RIG-I specifically 
recognizes short dsRNA bearing a 5’ end diphosphate or 
triphosphate group (5’pp or 5’ppp) [18, 19]. Upon viral RNA 
recognition, RIG-I recruits the adaptor protein MAVS which 
triggers a series of signaling cascades leading to the 
activation of the transcription factors NF-κB, IRF3, and IRF7 
[20]. An increasing body of evidence suggests that STING has 
a critical role in signaling pathways responding to RNA viral 
infections [21-23]. However, compared to the general 
requirement of STING in cytosolic DNA pathogen sensing, 
the mechanisms of STING modulation of RNA viral sensing 
remain less clear. Nevertheless, both DNA- and 
RNA-triggered innate immune responses converge at the 
STING-TBK1-IRF3 axis. Activated STING recruits and 
activates TBK1, leading to the activation of the IRF 
transcription factors and NF-kB, which triggers the induction 
of type I IFN and inflammatory cytokines [1]. 
Previous work from Goulet et al. observed an increase in 
STING gene expression following RIG-I agonist stimulation 
in a microarray analysis [24]. In the present study, Liu et al. 
validated this finding and further characterized the 
mechanism of RIG-I-mediated STING induction. To start, 
STING expression was observed to be induced by Sendai 
virus (SeV), a negative-sense single stranded RNA virus, 
among different cell types both at the protein and mRNA 
levels. In addition, in vivo, the authors detected an 
up-regulation of STING in the lung, liver, and spleen of 
C57BL/6 mice after RIG-I agonist 5’pppRNA stimulation. 
By employing various signaling deficient cell lines, 
SeV-mediated STING upregulation was shown to be 
exclusively activated by RIG-I. In addition, both 
MAVS-deficient mice and IFNAR-deficient mice displayed 
lower STING levels following 5’pppRNA inoculation. A 
detailed characterization of STING mRNA and protein 
expression following the 5’pppRNA treatment revealed 
significant increases at 24 hrs and 48 hrs in A549 epithelial 
cells. Altogether, these results suggest that RIG-I signaling 
leads to STING induction, and STING belongs to the group 
of late RIG-I-inducible genes. 
The authors hypothesized that this delay resulted from the 
secretion of regulatory factors into the supernatant. Indeed, 
the incubation of fresh cells with the supernatants of 
5’pppRNA treated cells triggered STING induction. In 
agreement with other publications demonstrating STING as 
an ISG [25], IFN-α treatment alone increased STING 
expression levels. More surprisingly, a remarkably high level 
of STING induction was achieved, not by the addition of a 
mixture of type I and type III IFNs, but by the co-stimulation 
of TNF-α and type I IFNs. Notably, the knockdown of TNFR 
and IFNα/βR, although significant, did not diminish the 
5’pppRNA triggered STING expression completely, 
suggesting the possibility of other cytokine(s) driven STING 
induction. These results reinforced the notion that the 
antiviral response is not potentiated by cytokines acting 
independently, but rather simultaneously and synergistically. 
In fact, the synergistic activity of type I IFN and TNF-α has 
long been reported to elicit distinct antiviral states defined by 
a panel of late genes [26]. The authors further identified the 
mechanisms involved in IFN- and TNF-α- dependent 
induction of STING. They observed a significant decrease of 
STING expression when transcription factors STAT1, 
STAT2, and the RELA subunit of NF-κB were depleted. 
This data suggests that synergistic TNF-α and type I IFN 
induction of STING expression is mediated by the 
convergence of the STAT and NF-κB pathways. 
Since STING is a key element in the establishment of 
antiviral states, the authors evaluated its contribution to the 
immune response triggered by 5’pppRNA. The knockdown 
of STING using siRNA significantly sustained the 
expression of immune response genes including IFNB1, 
IRF7, TNFAIP3, DDX58, and IFIT1 at 72 h and 96 h. Given 
that 5’pppRNA stimulation could protect cells against a wide 
range of DNA, RNA and retroviruses including vaccinia 
virus, influenza virus, hepatitis C virus, dengue virus, 
chikungunya virus and HIV-1 [24, 27], the authors next 
investigated whether the STING-mediated persistence of 
immune response gene expression has any contribution to the 
later time point viral resistance. Their data showed that in the 
5’pppRNA pretreated cells, the HSV-1 replication status at 
48 h of infection is inversely proportional to the expression 
level of STING. In other words, 5’pppRNA treated cells 
were significantly resistant to HSV-1 in the presence of 
STING. Correspondingly, those cells also displayed stronger 
immune responses at later times of HSV-1 infection. In 
contrast, the antiviral effect of 5’pppRNA in the context of 
an RNA viral infection was shown to be independent of 
STING. Taken together, the authors demonstrated that 
STING plays an active role in the 5’pppRNA-mediated 
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restriction of HSV-1. 
Furthermore, the authors verified the contribution of 
STING during the 5’pppRNA-mediated HSV-1 protection in 
vivo.  In agreement with other publications, STING 
deficient mice were significantly less likely to survive 
HSV-1 infection [28]. C57BL/6 mice weight loss was 
significantly reversed when pre-treated with 5’pppRNA, and 
were 100% protected from lethal infection with HSV-1. On 
the contrary, none of the STING deficient mice were rescued 
by 5’pppRNA pre-treatment, suggesting the vital role of 
STING during HSV-1 infection. Meanwhile, the authors 
detected in the STING deficient mice a remarkably lower 
serum level of IFN-β and correspondently higher viral loads 
in the lungs compared to the control mice. This data well 
correlated to the authors’ in vitro demonstrations and 
strengthened their findings on the necessity of STING during 
the 5’pppRNA protection against HSV-1 infection. 
In summary, Liu et al. have demonstrated that 
RIG-I-mediated STING up-regulation is vital for 5’pppRNA 
protected HSV-1 infection both in vitro and in vivo. While 
this study has provided new insight into the mechanisms 
involved in the regulation of STING, there are still several 
important questions which remain to be addressed in future 
studies. A recent study has discovered a STAT1 binding site 
in the promoter region of STING as critical for its induction 
by IFNs [25]. Does the TNF and IFN synergy induce STING 
expression at the transcriptional level through STAT1 and/or 
NF-κB binding sites in the STING promoter? In addition, 
since IL-1β, another NF-κB activator, failed to synergize 
with IFN for STING induction, it seems quite possible that 
other regulatory factors are involved. It would also be 
interesting to investigate the effects of STING-sustained 
interferon and the inflammatory response in the host innate 
immune defence against other DNA, RNA, bacterial 
pathogens, as well as in inflammatory disorders and 
autoimmune diseases. In regards to the crosstalk between 
DNA and RNA sensing, what are the potential roles of RNA 
sensing mechanisms in the activation of immune responses 
for the control of DNA pathogen infections? How is the 
DNA immune sensing involved in regulating the expression 
of molecules in RNA sensing pathways? Could pathogen 
RNAs be recognized by cytosolic DNA receptors? Further 
investigations on some of these topics may elucidate the 
complexities of the regulation of STING during innate 
immune signaling and provide new insight into the 
homeostatic control of host antiviral immune responses. 
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